. Author manuscript; available in PMC: 2013 Nov 20.

Published in final edited form as: J Nutr Biochem. 2009 Aug 27;21(8):695–701. doi: 10.1016/j.jnutbio.2009.04.003

Table 3.

The effect of β-glucan extracts on the in vitro intestinal uptake of 18:0, 18:2 and cholesterol under conditions where the UWL resistance was high (bulk phase was unstirred)

	In vitro intestinal uptake (nmol 100 mg⁻¹ min⁻¹)
	Control	Extract 1 (HP, HV barley)	Extract 2 (HP, LV barley)	Extract 3 (HP, HV oat)	Extract 4 (HP, LV oat)	Extract 5 (MP, HV barley)
Jejunum
18:0	0.34±0.06	0.19±0.04	0.21±0.04	0.27±0.07	0.23±0.03	0.18±0.04
18:2	0.42±0.07	0.20±0.04^*	0.19±0.03^*	0.10±0.02^*	0.27±0.06^*	0.06±0.02^*
Cholesterol	0.35±0.02	0.30±0.04	0.31±0.04	0.32±0.03	0.25±0.02	0.34±0.02
Ileum
18:0	0.28±0.04	0.25±0.05	0.24±0.04	0.24±0.04	0.29±0.04	0.27±0.06
18:2	0.66±0.09	0.02±0.03^*	0.33±0.11^*	0.27±0.05^*	0.14±0.03^*	0.12±0.03^*
Cholesterol	0.38±0.03	0.23±0.08	0.37±0.03	0.29±0.03	0.30±0.03	0.39±0.03

The lipids were solubilized in 20 mM taurodeoxycholic acid. The number of animals in each group was 8 (mean±S.E.M.).

Extract 1=HP, HV barley β-glucan; Extract 2=HP, LV barley β-glucan; Extract 3=HP, HV oat β-glucan; Extract 4=HP, LV oat β-glucan; Extract 5=MP, HV barley β-glucan.

Significantly different from control (ANOVA, SNK multiple-range test: P<.05). Comparisons were made within each row.